Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A clinical trial to assess the pharmacokinetics, safety, and food effect of AD-230 in healthy adults
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sequence A | Experimental | Period 1: Fasted, Period 2: Fed |
|
| Sequence B | Experimental | Period 1: Fed, Period 2: Fasted |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| AD-230 (Fasted) | Drug | AD-230 1Tab., Per Oral, Fasted |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Area under the plasma concentration-time curve during dosing interval (AUCt) | -24hours to 72hours | |
| Maximum concentration of drug in plasma (Cmax) | -24hours to 72hours |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Sarah Yoon | Contact | 031-891-5576 | sryoon@addpharma.co.kr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kyungpook National university hospital | Daegu | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| AD-230 (Fed) |
| Drug |
AD-230 1 Tab., Per Oral, Fed state |
|